BRN Discussion Ongoing

[rgupta]

Hi All
I know some like to rail against the corporate machine but it does seem that the majority of the anger is directed at Sean Hehir CEO.

The FACT of the matter is that he is clearly meeting the benchmarks given to him by the Board of establishing a global ecosystem of partners and sales opportunities supported by an experienced talented global sales and marketing team.

On the technology development side he has clearly accelerated the development timelines with the introduction of the 18 month development cycle for next generation product aligned with partner and customer requirements.

So from the Board’s perspective he is doing what he was employed to do and though some here and elsewhere are critical of the progress made on income growth the sales team has been booking deals such as EDGX/European Space Commission, VVDN EDGE Box, TATA Elxsi, Renesas, Unigen, MegaChips, Teksun, Socionext etc all of which are marketing AKIDA in the real world.

In short the bottom line is that looking from the outside it is difficult to see any basis for the Board to respond to the disgruntled and remove the CEO particularly when in the real world such action would likely lead to a significant payment for wrongful dismissal.

So what do these unhappy holders do. Threaten a second strike. But will this resolve their problem with the CEO.

Alas no because the pesky little CEO is not removed by a second strike it only affects the Directors.

Regardless in a spirit of butting their heads against the brick wall the second strike occurs and the same Directors are once again elected or even new Directors are elected they will still face a situation where the CEO is performant and his removal would be impossible.

To their dismay the disruption caused by the second strike and the 90 days at least of market uncertainty until the election of Directors takes place crushes the share price in an unprecedented fashion and their woes compound.

So what should these poor unhappy shareholders do?

1. They can write anonymous complaints on social media warning the public against investing because of the terrible CEO. This of course would not be a logical thing to do. It would be like advertising your car for sale and putting a sign on it saying don’t buy this car it’s a dog. No one would do this.

2. They could write to the company expressing their concerns privately in the hope that by pointing out their great expertise and qualifications in the commercialisation of world first technology the Company will take notice and implement their suggestions. Not an option for those who do not have this expertise of course.

3. They could decide to cut their losses and sell and move on to better performing investments.

4. They could as some investors claim to do put their shares in the bottom draw and forget about them on the basis that they have a belief that eventually the Company will prove to be the investment they hoped.

5. Cannot think of a fifth thing to do other than ignore this post and keep on doing what they are doing. Perhaps create some additional profiles on social media so they can appear to speak for a majority of shareholders. This of course would just further blunt market confidence so probably not a sensible option.

By the way Unigen is promoting yesterdays release on their website:

BrainChip and Unigen Partner to Deliver Powerful, Energy-Efficient Edge AI Server - Unigen

BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI IP, and Unigen Corporation, a global leader in the design and manufacturing of enterprise and industrial electronics, today announced...

unigen.com

My opinion only DYOR
Fact Finder

Merry Christmas to all genuine shareholders

Ff your view points are very valid and true.
Do you really think,it should be on a long term holder's mind right now. An AGM is at least 5 months away.
on the other hand we may start getting some revenue from renasas, vvdn, megachips by that time.
My second think tank is it will more than six months for akida 2000 official launch by that time and if we cannot struck a deal by that time that will mean two things
1. Company does not want to let market know about its customers but for how long?
2. The product is not getting any interest from the market.
In 1st instance it is very difficult for sp to sustain even these levels and the actual holders can look much different than present.
in the second condition I assume they deserved to be booted.
In all assumptions I cannot believe management is taking strike condition casually and must be having a plan to avoid the same.

Can we believe it will be more than three years from last ip signed with megachips.
yes we get a lot of partners since Sean joined but a lot of them are too small to make any difference in the real world unless they are working on a project from big organisations.
End of the day looking at present SP I would love to forget that I ever invested in brainchip than to sell on these prices.
FOr last 4 years since I started investing in brainchip the only beneficiaries are day traders whether they buy and sell or short the stock. There is a lot of speculation but no revenue generation.
I wish 2024 will belong to long term holders and believers of brn.

 

[CHIPS]

​

We invite you to schedule a meeting at CES. Simply select a time slot here: BrainChip at CES. We look forward to sharing more with you about how BrainChip’s Akida technology pushes the limits of AI on-chip compute.

Check this and click on the link. There are not so many time slots left!

 

[manny100]

Hi David

At risk of forcing you and others to drink poisonous Cool Aide I will ask you these questions.

Did you know last Friday that Unigen was testing AKIDA technology and about to enter a partnership agreement to integrate AKIDA technology into its Cupcake Edge processor?

Do you know of anyway this could have occurred without some written agreement in relation to the AKIDA IP and without it being signed by Brainchip and Unigen?

Do you recall the CEO Sean Hehir stating that some companies they were dealing with do not want to be publicly disclosed?

Do you know with certainty if any of the known SBIR contracts involving AKIDA have failed and are not progressing?

Do you not consider that the additional IP licence fees paid by MegaChips of about $3 million more than the original advised amount was for sales made by MegaChips of the Brainchip IP to its customers?

Do you place any value on the VVDN AKIDA EDGE Box coming to market?

Probably too much Cool Aide so I will leave it there.

My opinion only DYOR
FACT FINDER

PS: For comic relief I sometimes browse HC and chuckled when one of the known trolls said Fact Finder isn’t he that guy who claimed Brainchip would be $1.00 by Christmas.

As uniformed as he is with only one purpose to undermine shareholder confidence he failed to check that the share price did go to $1.00.

To be successful negativity needs to have a factual basis.

It is an absolute certainty that Unigen had fully tested AKIDA before agreeing to partner with BRN. Otherwise they would not have disclosed on their website that Cupcake was going to include AKIDA.
From the Unigen website:
" “We are proud to collaborate with BrainChip to bring a new vision to the world of Edge AI solutions,” said Paul Heng, President, and CEO of Unigen. “The Cupcake Edge AI Server can unleash the full potential of AI technology. We look forward to expanding our AI partnership network with BrainChip to deliver a unique Cupcake configuration to customers who are looking for a smart, sustainable, and secure Edge AI solution.” "
Unigen service many industries including Health, Ato and Industrial.

 

[David holland]

Hi David

At risk of forcing you and others to drink poisonous Cool Aide I will ask you these questions.

Did you know last Friday that Unigen was testing AKIDA technology and about to enter a partnership agreement to integrate AKIDA technology into its Cupcake Edge processor?

Do you know of anyway this could have occurred without some written agreement in relation to the AKIDA IP and without it being signed by Brainchip and Unigen?

Do you recall the CEO Sean Hehir stating that some companies they were dealing with do not want to be publicly disclosed?

Do you know with certainty if any of the known SBIR contracts involving AKIDA have failed and are not progressing?

Do you not consider that the additional IP licence fees paid by MegaChips of about $3 million more than the original advised amount was for sales made by MegaChips of the Brainchip IP to its customers?

Do you place any value on the VVDN AKIDA EDGE Box coming to market?

Probably too much Cool Aide so I will leave it there.

My opinion only DYOR
FACT FINDER

PS: For comic relief I sometimes browse HC and chuckled when one of the known trolls said Fact Finder isn’t he that guy who claimed Brainchip would be $1.00 by Christmas.

As uniformed as he is with only one purpose to undermine shareholder confidence he failed to check that the share price did go to $1.00.

To be successful negativity needs to have a factual basis.

You maybe a lawyer or a ex 1 and what your saying is correct, however the punter out there whose pumped in alot of cash that could be used in other areas and taken a risk and is emotional with the lack of announcements and seen the price dip is starting to question his investment , I remember in early interviews Sean stating the market cap should be alot more at the time,,now where at 18 cents market cap of ? But we have 50 partners or IP's of 2 ,alot of people got in at a dollar , they are worried because the company say it's all a secret for our customers , People can't just sell they need to ride it out and I understand the frustration, I think it's fair enough if by May at the AGM the company talk a good game and nothing is happening in the shareprice, Shareholders voice there opinion, if Mercedes didn't drop our name at the time I wonder where the company may be in shareprice, In time I'm very hopeful and I'm heavily invested but it's very frustrating, I believe the partners and IP'S that We have our shareprice is a joke , It's a forum people can speak, people can put silly pictures up and bag people but it's hard earned cash people have put up, They are voicing there opinion and to me it's fair enough, Everybody here are rooting for BRN To succeed and once the shareprice goes up people will calm down

 

[Neuromorphia]

Brainchip Akida Ecosystem updated

 

[MDhere]

View attachment 52317

PS: The guy on the second video said the E core is the one that contains the AI.

Somewhere in dodgyknees reply is the answer

 

[MDhere]

You maybe a lawyer or a ex 1 and what your saying is correct, however the punter out there whose pumped in alot of cash that could be used in other areas and taken a risk and is emotional with the lack of announcements and seen the price dip is starting to question his investment , I remember in early interviews Sean stating the market cap should be alot more at the time,,now where at 18 cents market cap of ? But we have 50 partners or IP's of 2 ,alot of people got in at a dollar , they are worried because the company say it's all a secret for our customers , People can't just sell they need to ride it out and I understand the frustration, I think it's fair enough if by May at the AGM the company talk a good game and nothing is happening in the shareprice, Shareholders voice there opinion, if Mercedes didn't drop our name at the time I wonder where the company may be in shareprice, In time I'm very hopeful and I'm heavily invested but it's very frustrating, I believe the partners and IP'S that We have our shareprice is a joke , It's a forum people can speak, people can put silly pictures up and bag people but it's hard earned cash people have put up, They are voicing there opinion and to me it's fair enough, Everybody here are rooting for BRN To succeed and once the shareprice goes up people will calm down

Ok David i have to say something here...
1. All and i mean ALL those invested here whether its 18c or $1 as you put it even higher, so im not excluding any shareholders. ALL are invested, ALL "hopefully" know why they invested their "hard earned cash" as you put it. So if ALL did this at no matter what price even on the Mercedes déclaration they did that because of their research.
So may i then also say this to ease your concern of those that you speak of, given what i have just stated above is it not unreasonable the investors are knowledgeable and invested at whatever the price due to their research. Not sure what group yr nurturing but what i can say is those that you speak of are not silly people and i would suggest not to make them out as such.
They did their research and they invested. Now they have either got dementia and have no idea what they did or they averaged down or they know what they are doing.
Hope this makes sense to you and you can relay this concept to those investorsthat you are refererring to. X ps also i noticed i only labelled the conversation 1. (No. 1. Was long enough)

 

[Pom down under]

View attachment 52326 yes

Lol

 

[Pom down under]

Out of this list 2 are IP Customers, Surely of the 50 not all of the mentioned can be ,however 2 IP Licenses is poor at this stage, a CEO who is still on zero with IP'S,
Apparently kicked many goals but it comes down to contracts and potentially revenue that builds a future,
Would you agree Fact Finder come the nxt AGM if the company is still at 2 and little revenue coming in the natives may become a little restless, and probably so,
Atm it's like his got the fans coming to games and talking a real fine game ,however the team isn't kicking the goals to win the game, hence the shareprice being raped and people losing interest

 

[Pom down under]

Hi David

At risk of forcing you and others to drink poisonous Cool Aide I will ask you these questions.

Did you know last Friday that Unigen was testing AKIDA technology and about to enter a partnership agreement to integrate AKIDA technology into its Cupcake Edge processor?

Do you know of anyway this could have occurred without some written agreement in relation to the AKIDA IP and without it being signed by Brainchip and Unigen?

Do you recall the CEO Sean Hehir stating that some companies they were dealing with do not want to be publicly disclosed?

Do you know with certainty if any of the known SBIR contracts involving AKIDA have failed and are not progressing?

Do you not consider that the additional IP licence fees paid by MegaChips of about $3 million more than the original advised amount was for sales made by MegaChips of the Brainchip IP to its customers?

Do you place any value on the VVDN AKIDA EDGE Box coming to market?

Probably too much Cool Aide so I will leave it there.

My opinion only DYOR
FACT FINDER

PS: For comic relief I sometimes browse HC and chuckled when one of the known trolls said Fact Finder isn’t he that guy who claimed Brainchip would be $1.00 by Christmas.

As uniformed as he is with only one purpose to undermine shareholder confidence he failed to check that the share price did go to $1.00.

To be successful negativity needs to have a factual basis.

Maybe we should play a game off

 

[Tothemoon24]

Wevolver on LinkedIn: Technology has made significant strides in replicating human senses and…

Technology has made significant strides in replicating human senses and mimicking the sense of smell. Electronic noses (e-noses), devices designed to detect…

www.linkedin.com

​

​

Neuromorphic E-Noses in Medical and Industrial Applications​

BrainChip Team
fromBrainChip
18 Dec, 2023

FOLLOW

Exploring the Fusion of Neuromorphic Computing and Electronic Noses for Advanced Sensory Solutions​

Artificial Intelligence
- Edge Processors
- Sensors
This article is a summary of the full white paper "Finding Bacteria in Blood: Scaling A Hardware-Driven Neuromorphic Solution for Real-World E-Nose Applications". Read it here.

Neuromorphic approach to replicating human senses​

Technology has made significant strides in replicating human senses and mimicking the sense of smell. Electronic noses (e-noses), devices designed to detect and analyze odors, have become integral in medical diagnostics and food quality control. However, current e-nose technologies face portability, energy efficiency, and accuracy limitations. Recent research presents an innovative neuromorphic approach, using spiking neural networks and data-to-spike encoding, to overcome these challenges, offering a more effective and practical e-nose solution.

The Experiment: Detecting Bacteria in Blood​

Dataset Overview​

The 'bacteria in blood' dataset, integral to this research, was collected as part of the Mednose project at Örebro University. This dataset is pivotal for the early detection of various bacterial species in blood samples, serving as a critical tool for rapid and accurate diagnostics. It encompasses a comprehensive collection of 1200 samples, with each of the ten bacterial species represented by 120 samples. This extensive dataset is instrumental in understanding the unique chemical signatures emitted by different bacteria, which is crucial for effective diagnosis and treatment strategies.

Data Preprocessing and Encoding​

The preprocessing of this dataset involves baseline cancellation to eliminate background noise and scaling of sensor responses for consistency. Two innovative encoding algorithms, Address Event Representation for Olfaction (AERO) and Step Forward (SF), were employed to convert sensor data into a digital format. AERO structures sensor information into a grid, creating digital snapshots of scents. SF focuses on changes in odor data exceeding a certain threshold, inspired by the human sensory system's attention to dynamic information. These algorithms effectively capture and interpret the complex odor signatures associated with different bacteria types.
The Akida™ classifier model developed in this study demonstrated a high classification accuracy of 97.42% in identifying ten different bacteria species, marking a significant advancement in electronic noses and neuromorphic computing.

Achieving High Accuracy and Efficiency​

In neuromorphic computing, enhancing electronic noses (e-noses) for practical applications such as detecting bacteria in the blood and optimizing the Spiking Neural Network (SNN) is crucial. This optimization is essential for effective odor detection, impacting the system's accuracy, efficiency, and speed.

Optimization Strategies​

The optimization of the SNN in this context involves fine-tuning various parameters and structures to maximize the efficiency of odor detection. Key aspects include adjusting the number of neurons associated with each odor class, the active connections each neuron should have, and the intensity of learning competition among neurons. This process ensures that the SNN can accurately identify patterns in the incoming data and respond rapidly, effectively mimicking the human brain's neuronal activity.
These optimizations are rooted in biological processes like Spike Time Dependent Plasticity (STDP), which allows the network to strengthen synaptic connections based on frequently encountered activation patterns. This learning mode is fundamental to how the brain adapts and responds to sensory input, making it an ideal model for neuromorphic systems like the Akida NSoC.

Performance Evaluation​

The performance of the optimized SNN is evaluated based on several critical factors: classification accuracy, power efficiency, and speed of odor detection. In the case of detecting bacteria in blood, the system demonstrated high mean classification accuracies, especially with the early data points in the sampling process. This indicates that the essential features for odor differentiation are present early on, allowing for rapid and accurate classification.
Power efficiency is another crucial metric directly impacting the system's viability in practical applications. The optimized SNN, as implemented in the Akida NSoC, shows remarkable energy efficiency, consuming minimal power while maintaining high throughput. This aspect is essential for portable or remote applications where power resources are limited.
The speed of odor detection is the final critical measure of the system's performance. The optimized SNN demonstrates the ability to process and classify odors swiftly, a vital feature for applications requiring real-time analysis, such as medical diagnostics or food quality control.
Optimizing the SNN for e-nose applications, as demonstrated in the Akida NSoC, represents a significant advancement in neuromorphic technology. It combines high accuracy, energy efficiency, and speed. It is a promising solution for real-world applications in healthcare diagnostics and other sectors where rapid and reliable odor detection is crucial.

Real-World Applications and Implications​

As demonstrated in the study "Finding Bacteria in Blood," neuromorphic technology shows immense potential in transforming healthcare and rapid disease diagnosis. This technology can significantly speed up the identification of various strains of bacteria in the blood, which is crucial for diagnosing diseases accurately and promptly. Its portability and accuracy make it an invaluable tool in remote locations or outside traditional clinical facilities, providing critical healthcare services in underserved areas.
Beyond healthcare, neuromorphic technology has broader applications in agriculture, environmental monitoring, and industrial processes. Its ability to mimic human sensory systems allows for advanced detection and analysis capabilities, making it a valuable tool for quality control in food production, pollutant detection, and much more.

Conclusion​

The advancements in neuromorphic technology, in sensory applications like electronic noses, herald a new era in AI and machine learning. Its transformative potential lies in bringing more efficient, accurate, and low-power solutions to real-world challenges. As this technology continues to evolve, it promises to revolutionize numerous industries, improving processes and outcomes across multiple sectors.

Additional Information​

Please refer to the white paper "Finding Bacteria in Blood: Scaling A Hardware-Driven Neuromorphic Solution for Real-World E-Nose Applications" for further reading and detailed insights. It provides an in-depth exploration of the technology and its applications. Additionally, for a broader understanding of neuromorphic applications in medicine, the paper "Neuromorphic applications in Medicine," published on PubMed, offers a comprehensive overview.

References​

1. https://brainchip.com/wp-content/uploads/2023/11/Bacteria-in-Blood-research-paper_Final.pdf
2. https://brainchip.com/finding-bacte...-solution-for-real-world-e-nose-applications/
3. https://pubmed.ncbi.nlm.nih.gov/37531951/#:~:text=Neuromorphic engineering, which uses neural,footprint, and high bandwidth solutions.
4. https://brainchip.com/akida-neural-processor-soc/
5. https://brainchip.com/akida-neural-processor-ip/

 

[wilzy123]

the punter out there whose pumped in alot of cash that could be used in other areas and taken a risk and is emotional with the lack of announcements and seen the price dip is starting to question his investmen

This sounds like the epitome of financial investment. Please continue to teach us of your ways.

 

[Colorado23]

Evening all
As always, thanks for most of your contributions. Excited as ever.
Just wondered what we thought the chances were of Mercedes lifting the lid on the Concept CLA Class with akida under the boot at CES.

 

[IloveLamp]

Evening all
As always, thanks for most of your contributions. Excited as ever.
Just wondered what we thought the chances were of Mercedes lifting the lid on the Concept CLA Class with akida under the boot at CES.

 

[JDelekto]

Hi David

At risk of forcing you and others to drink poisonous Cool Aide I will ask you these questions.

Did you know last Friday that Unigen was testing AKIDA technology and about to enter a partnership agreement to integrate AKIDA technology into its Cupcake Edge processor?

Do you know of anyway this could have occurred without some written agreement in relation to the AKIDA IP and without it being signed by Brainchip and Unigen?

Do you recall the CEO Sean Hehir stating that some companies they were dealing with do not want to be publicly disclosed?

Do you know with certainty if any of the known SBIR contracts involving AKIDA have failed and are not progressing?

Do you not consider that the additional IP licence fees paid by MegaChips of about $3 million more than the original advised amount was for sales made by MegaChips of the Brainchip IP to its customers?

Do you place any value on the VVDN AKIDA EDGE Box coming to market?

Probably too much Cool Aide so I will leave it there.

My opinion only DYOR
FACT FINDER

PS: For comic relief I sometimes browse HC and chuckled when one of the known trolls said Fact Finder isn’t he that guy who claimed Brainchip would be $1.00 by Christmas.

As uniformed as he is with only one purpose to undermine shareholder confidence he failed to check that the share price did go to $1.00.

To be successful negativity needs to have a factual basis.

I would be curious to know whether other companies, disclosed as partners or otherwise, have been working on taping out their designs in secret using BrainChip's IP.

Is it possible that companies have been working on products, possibly only paying for engineering and support along the way, only to sign an IP agreement after they have a product ready for market?

Except for providing an obvious revenue stream, at what point must an engagement with a company require an ASX announcement? Would this include signing a non-binding letter of intent be a requirement, or must it be a binding agreement in which payments are arranged?

Would these letters of intent or support engagements be disclosed differently if the company were private or public?

I'm curious as to whether or not there are some surprises to be had. It seems like the recent Edge server announcement by Unigen wouldn't have been made off the cuff and would have had to have some serious research and consideration.

 

[DingoBorat]

View attachment 52302

For some reason that picture reminded me of this, the Era and the cigarette, I guess..

Ahh I'm really looking forward to holidaying in Ipanema one day and feeling the blissful cutting sting, of being ignored by beautiful women..

 

[DingoBorat]

Hi All
Some will recall that I have previously posted a list of companies and institutions which have been confirmed as engaged with Brainchip either by Press Release, academic papers, ASX announcements or direct communications with the Director Investor Relations or the CEO Sean Hehir. Today I updated my list and was pleased to see that it has now reached 50 in number so I thought it was time to post it again here:

1. FORD

2. VALEO

3. RENESAS

4. NASA

5. TATA Consulting Services

6. MEGACHIPS

7. MOSCHIP

8. SOCIONEXT

9. PROPHESEE

10. VVDN

11. TEKSUN

12. Ai LABS

13. NVISO

14. EMOTION 3D

15. ARM

16. EDGE IMPULSE

17. INTEL

18. GLOBAL FOUNDRIES

19. BLUE RIDGE ENVISIONEERING

20. MERCEDES BENZ

21. ANT 61

22. QUANTUM VENTURA

23. INFORMATION SYSTEM LABORATORIES

24. INTELLISENSE SYSTEMS

25. CVEDIA

26. LORSER INDUSTRIES

27. SiFIVE

28. IPRO SILICONE

29. SALESLINK

30. NUMEN

31. VORAGO

32. NANOSE

33. BIOTOME

34. OCULI

35. CIRCLE8 CLEAN TECHNOLOGIES

36. AVID GROUP

37. TATA ELXSI

38. GMAC INTELLIGENCE

39. EDGX

40. EUROPEAN SPACE AGENCY

41 UNIGEN

42. iniVation

43. SAHOMA CONTROLWARE

44. MAGIK EYE

45. University of Virginia

46. University of Oklahoma

47. Arizona State University

48. Carnegie Mellon University

49. Rochester Institute of Technology

50. Drexel University

My opinion only DYOR
Fact Finder

This from an email, from Tony Dawe in July this year, where I asked for the approximate number of engagements (Louis DiNardo once saying it was North of 100).

He said this..

"The number of engagements we have is commercially confidential. You can reasonably assume that it is many times larger than the number of known engagements that we have announced"

That was around 40 at the time and "many times larger" indicates 40 x a number, at least more than 3 to me.

I think a number now approaching 200, is reasonable to "assume"..

There would undoubtedly be some very big cheeses, sprinkled in with that lot

 

[Diogenese]

I would be curious to know whether other companies, disclosed as partners or otherwise, have been working on taping out their designs in secret using BrainChip's IP.

Is it possible that companies have been working on products, possibly only paying for engineering and support along the way, only to sign an IP agreement after they have a product ready for market?

Except for providing an obvious revenue stream, at what point must an engagement with a company require an ASX announcement? Would this include signing a non-binding letter of intent be a requirement, or must it be a binding agreement in which payments are arranged?

Would these letters of intent or support engagements be disclosed differently if the company were private or public?

I'm curious as to whether or not there are some surprises to be had. It seems like the recent Edge server announcement by Unigen wouldn't have been made off the cuff and would have had to have some serious research and consideration.

Hi JD,

The possible terms of an agreement are practically limitless. It is how the parties agree to proceed.

Most of the engagements have been termed "partnerships" to develop a product incorporating Akida for the customer's purposes.

Generally the profits of a partnership are distributed on the basis of the partners' contributions.

However, it is possible that the partnership's objective is to design a product, and then for the enterprise to morph into a licence arrangement. BRN's contribution to the design process would include the Akida IP, engineering support, and know-how. Once the design is complete, BRN would not need to be involved in the commercial production and marketing of the product.

The letter of intent would have been designed to cover the initial stages of negotiations. Certainly no IP would have been provided on the basis of a non-binding letter of intent.

Business negotiations are usually commercial-in-confidence whether the parties are private or public.

 

[Deadpool]

This from an email, from Tony Dawe in July this year, where I asked for the approximate number of engagements (Louis DiNardo once saying it was North of 100).

He said this..

"The number of engagements we have is commercially confidential. You can reasonably assume that it is many times larger than the number of known engagements that we have announced"

That was around 40 at the time and "many times larger" indicates 40 x a number, at least more than 3 to me.

I think a number now approaching 200, is reasonable to "assume"..

There would undoubtedly be some very big cheeses, sprinkled in with that lot

Blessed are the cheese makers.

*Ode to Blue Vein Cheese*

In the caverns of dairy, where molds conspire,
A masterpiece emerges, bold and dire.
Blue veins weave through curds, a celestial dance,
Penicillium whispers secrets, takes its chance.

Oh, my proverbial has just moved to the thought of 200

 

[Bravo]

For some reason that picture reminded me of this, the Era and the cigarette, I guess..

Ahh I'm really looking forward to holidaying in Ipanema one day and feeling the blissful cutting sting, of being ignored by beautiful women..

Well you’re wrong there because I go to Ipanema all the time and I would never ignore you!